New inhaler cocktail aims to ease lung damage in ICU patients
NCT ID NCT07286409
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a combination of three inhaled drugs (furosemide, heparin, and hypertonic saline) can reduce lung injury in adults with acute respiratory distress syndrome (ARDS) who are on mechanical ventilators. The trial will involve 344 participants and measure daily lung function scores. The goal is to find a supportive treatment to control the disease and prevent further lung damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of medicine, Tanta university
Tanta, El Gharbyia, 31111, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can gentle oscillations help premature babies breathe better?
- Can a Lung-Opening maneuver change a key injury marker in ARDS?
- Could simply sitting up ease breathing in severe lung failure?
- Could lung fluid proteins reveal a new way to track severe lung injury?
- Could a tiny tube spare preterm babies from breathing machines?
- Could a spirometer test guide breathing support in respiratory failure?